Aug 2026· Drug Design, Development and Therapy· Vol 20, pp. 1-10· 0 citations· 29 references
Medicine
TL;DR
Preoperative dexamethasone ≥10 mg was associated with improved short-term postoperative outcomes in elderly gastric cancer patients, while the dose <10 mg only correlated with lower acute coronary syndrome risk.
Abstract
Background Optimizing postoperative recovery for elderly gastric cancer patients is of great clinical significance. This retrospective cohort study aimed to explore the association between preoperative use of dexamethasone and postoperative outcomes in elderly patients undergoing gastric cancer resection. Methods In this retrospective cohort study, elderly patients who underwent gastric cancer resection were enrolled. Baseline and perioperative data including use of dexamethasone for antiemetic purpose were collected. Patients were divided into control group (no dexamethasone), low-dose group (< 10 mg) and high-dose group (≥ 10 mg) based on the dose of dexamethasone administered preoperatively on the discretion of anesthesiologists. The primary endpoint was postoperative length of hospital stay (pLOS), defined as the duration from surgery to initial discharge (prolonged pLOS referred to pLOS ≥ median pLOS of all patients). The association between perioperative dexamethasone use and prolonged pLOS were analyzed with multivariable logistic regression models. Dose-response trend test and sensitivity analysis were conducted to confirm the reliability of the findings. Results The high-dose group had significantly shorter pLOS and lower overall complication rate than the control group (10 [9–13] vs 13 [10–17] days, P = 0.010; 20.9% vs 41.9%, P = 0.011). After adjusting for multiple confounders, preoperative dexamethasone ≥10 mg was independently associated with shorter pLOS (OR 0.355, 95% CI 0.166–0.756, P = 0.007). The high-dose group showed lower risks of pulmonary infection and surgical site infection. Both dexamethasone groups had reduced incidence of acute coronary syndrome. Conclusion Preoperative dexamethasone ≥10 mg was associated with improved short-term postoperative outcomes in elderly gastric cancer patients, while the dose <10 mg only correlated with lower acute coronary syndrome risk. These observational associations need further prospective validation.
Importance
Modulating perioperative inflammation could be associated with fewer postoperative complications and better outcomes in major digestive surgery. The clinical benefit of corticosteroids with this purpose remains controversial.
Objective
To assess whether preoperative high-dose corticosteroids improve postop...
P. Ortega-Deballon, A. Bourredjem, J. Regimbeau et al.· JAMA Surgery· 2 citations
Background Japan’s rapidly aging population has led to an increase in elderly patients undergoing gastrectomy for gastric cancer. However, the impact of postoperative complications on survival in patients aged ≥80 years remains unclear. This study aimed to evaluate the association between postoperative complications an...
INTRODUCTION
Prolonged postoperative length of stay (PLOS) is a relevant indicator of clinical outcomes and healthcare efficiency after colon cancer surgery. Identifying predictive factors may improve perioperative planning and resource allocation.
METHODS
A retrospective observational study was conducted in patients...
B. R. Serrano, José Luis Duro-Torrijos, Jesús Sánchez Más et al.· Cirugia Española· 0 citations
A low preoperative PNI is an independent predictor of postoperative delirium in elderly patients undergoing spine surgery and proves it in a retrospective case-control study.
H. Oh, Hoo Seung Lee, Suk Hyung Choe et al.· Clinical Spine Surgery· 0 citations
Wedge resection represents a safe alternative to anatomical resection in selected elderly patients, with comparable survival outcomes and reduced perioperative burden, and Careful preoperative selection remains essential.
C. Zirafa, Beatrice Manfredini, Elisa Sicolo et al.· European Journal of Surgical...· 0 citations
Background: Cancer is primarily a disease of older adults, with over 50% of new diagnoses and 70% of mortality occurring in individuals over 65 years. Despite this heavy burden, older patients remain severely underrepresented in landmark oncology clinical trials. Unfounded fears of high postoperative morbidity often le...
D. Kurdiani· Japan Journal of Clinical &a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.